October 3, 2014 / 2:08 PM / 3 years ago

BUZZ-U.S. Stocks on the Move-Cliffs Natural, Tekmira, Mylan, Iamgold

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were higher on Friday after the September jobs report came in ahead of expectations, though major indexes remained on track for a second straight weekly decline. The Dow Jones industrial average was up 1.05 percent at 16,977.55 and the S&P 500 was up 1.06 percent at 1,966.87.

** RADIOSHACK CORP, Thursday close $0.99

Trading in the shares, which were up about 37 percent before the bell, was halted at 9:15 a.m. ET.

The company reached an agreement with a consortium led by its largest shareholder, Standard General LP, to refinance about $590 million of loans, according to Bloomberg.

Last week, Standard General said it was in talks to improve RadioShack's cash position ahead of the crucial holiday shopping season

** TEKMIRA PHARMACEUTICALS CORP, $26.84, +5.38 pct

The company said it had achieved a $1.5 million development milestone. Maxim raised its price target on the stock to $31 from $23.

** SALIX PHARMACEUTICALS, $158.725, +5.05 pct

Salix and Swiss-listed Cosmo Pharmaceuticals SpA said they have terminated their merger agreement, citing a "changed political environment".

The Obama administration took several actions last month to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad.

Credit Suisse upgraded the stock to "neutral" from "underperform" and raised its price target to $155 from $139.

** GOOGLE INC, $587.14, +1.08 pct

The software giant plans to launch a mobile messaging app it is likely to test in India and other emerging markets, the Economic Times newspaper reported on Friday, citing sources.

** MYLAN INC, $49.65, +6.77 pct

The company's shares rose on rumors of a merger with Teva Pharmaceuticals, according to Benzinga.com. (bit.ly/1BDiztJ)

Mylan also raised its third-quarter adjusted profit forecast to $1.12-$1.16 per share from 90-95 cents per share, citing stronger-than-expected operational performance.

** FACEBOOK INC, $77.93, +1.10 pct

European Union antitrust regulators approved on Friday a $19 billion offer by the world's most popular social network, for mobile messaging startup WhatsApp.

The landmark deal is the largest in Facebook's 10-year history and will give it a strong foothold in the fast-growing mobile messaging market, pitting it against telecoms companies.

In another development, on the heels of fellow Silicon Valley technology companies Apple Inc and Google Inc , Facebook is also plotting its first steps into the fertile field of healthcare, said three people familiar with the matter.

** CONSTELLIUM NV, $23.4, +0.34 pct

The aluminum products maker said it is to acquire U.S. peer Wise Metals for $1.4 billion, including debt, in a deal aimed at tapping into fast-growing demand from car makers for aluminum sheet.

** CLIFFS NATURAL RESOURCES, $9.24, -7.60 pct

Nomura cut its rating on the stock to "reduce" from "buy", and price target to $5 from $18. Analysts at Nomura said a fall in iron ore prices this year has hurt company's results and will limit its ability to sell assets.

** UBS AG, $16.82, -2.21 pct

Switzerland's largest bank could face a fine of up to $6.3 billion if found guilty in a French investigation into whether it helped wealthy customers there avoid tax, a Swiss newspaper reported on Friday [ID: nL6N0RY0R6]

** IAMGOLD CORP, $2.61, -4.40 pct

The company said it would sell its Niobec rare earths mine in Quebec to a group of companies led by investment company Magris Resources Inc for $500 million in cash, to focus on its core gold mining business.

** WALGREEN CO, $61.62, +3.11 pct

The largest U.S. drugstore operator's September sales rose 9.4 percent to $6.48 billion as pharmacy sales increased 14.2 percent.

Comparable-store sales rose 7.9 percent, with prescriptions filled at those stores increasing 6.6 percent.

** WELLPOINT INC, $120.99, +2.14 pct

The U.S. health insurer increased its share repurchase authorization by $5 billion, taking the total program to $6 billion, the company said in a regulatory filing.

WellPoint, which runs Anthem and Empire Blue Cross Blue Shield Plans, said the authorization is for a multi-year period. (1.usa.gov/1oFGu5U)

** GOLDMAN SACHS GROUP INC, $186.03, +1.72 pct

The financial group is considering raising a new infrastructure fund, according to three people familiar with the matter, even as U.S. regulations threaten to reduce its profits from such endeavors.

** WALT DISNEY CO, $88.65, +2.14 pct

The company's board extended chairman and chief Executive Bob Iger's contract through June 2018, keeping him at the helm of the media and theme park company two years longer than he previously planned.

** RIO TINTO PLC, $47.45, -3.14 pct

Turquoise Hill Resources Ltd, majority owned by Rio Tinto , said on Thursday that it was still in talks with the Mongolian government to resolve issues that delayed underground expansion of its Oyu Tolgoi gold and copper mine.

** LEGACY RESERVES LP, $27.25, -4.22 pct

The oil and gas producer said it plans to sell 10 million units, representing about 17 percent of outstanding units.

Legacy, which did not disclose pricing of the offering, said it planned to use the proceeds from the share sale to repay debt and fund acquisitions.

** RESOURCES CONNECTION INC, $14.72, +1.10 pct

Baird raised its price target on the stock to $17 from $16. Resources Connection's expense discipline is leading to material margin improvement, Baird analyst Mark Marcon wrote in note. (Compiled by Amrutha Penumudi in Bangalore; Edited by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below